(CORONA, Calif.)Watson Pharmaceuticals Inc. said late Wednesday the Food and Drug Administration approved its drug Rapaflo for the treatment of urinary problems. The drug is approved as a treatmen...READ MORE

(CORONA, Calif.)Watson Pharmaceuticals Inc. on Wednesday presented updated information on the effectiveness of its experimental topical gel to treat overactive bladder syndrome.READ MORE

(CORONA, Calif.)Drugmaker Watson Pharmaceuticals Inc. said Wednesday the patent on its overactive bladder patch Oxytrol is being challenged. Watson said it has received a paragraph IV certificatio...READ MORE

(CORONA, Calif.)Watson Pharmaceuticals Inc. on Monday reported results from four late stage trials of its drug candidate silodosin, saying the drug was well tolerated and reduced symptoms of prost...READ MORE

(NEW YORK)A Wachovia analyst upgraded the generic drug sector on Monday, and raised his ratings on Teva Pharmaceutical Industries Ltd. and Watson Pharmaceuticals Inc. because they are tradin...READ MORE

Among the premarket activity stories for Tuesday, Sept. 16, from AP Financial News: NEW YORK (AP)--Regulated utilities remain an attractive investment in a low-interest rate enviro...READ MORE

(NEW YORK)Shares of generic drug developer Watson Pharmaceuticals Inc. could be ready for a downturn, while rivals Teva Pharmaceutical Industries Ltd. and Mylan Inc. are in more stable posit...READ MORE